Skip to content
buyWeak

Gary S Roubin bought $127k of NSPR

director at InspireMD, Inc.. 50,000 shares at an average of $2.53, traded Nov 30, 2023, filed Dec 4, 2023.

Conviction score
37
Value
$127k
50,000 shares
Holdings after
438,902
+13% from before
From 52-week low
+172%
low $0.85, close $2.31
From 52-week high
-39%
high $3.77, as of Nov 30, 2023

Score components

  • Role
    Director
    +15
  • Trade size
    $127k at market
    +11
  • Relative to holdings
    Holdings up 13%
    +3
  • Price context
    39% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NSPROct 9, 2026 · close 0.52
Since filing Dec 4, 2023: -78.8%SPY +76.7% · excess -155.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-23-043561, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 30, 2023POpen-market purchase
Common Stock
+50,000$2.53$127k438,902Dec 4, 2023

Related signals

Other insiders at InspireMD, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
NSPRbuy
InspireMD, Inc.
Paul Stuka
director
$18k
20,000 shares
+3%
27Weak
NSPRsell
InspireMD, Inc.
Shane Thomas Gleason
Chief Commercial Officer
$190k
85,295 shares
-7%
48Moderate
NSPRbuy 4
InspireMD, Inc.
Paul Stuka
director
$17k
15,000 shares
+2%
58Moderate
NSPRbuy 4
InspireMD, Inc.
Marvin Slosman
CEO and President
$25k
21,000 shares
+1%
45Moderate
NSPRbuy 410b5-1
InspireMD, Inc.
Paul Stuka
director
$88k
75,626 shares
+14%
45Moderate
NSPRbuy 410b5-1
InspireMD, Inc.
Paul Stuka
director
$88k
75,626 shares
+14%
61Notable
NSPRbuy 4
InspireMD, Inc.
Gary S Roubin
director
$106k
90,000 shares
+12%
43Moderate
NSPRbuy 4
InspireMD, Inc.
Paul Stuka
director
$9,034
7,895 shares
+2%
68Notable
NSPRbuy 4
InspireMD, Inc.
Scott R. Ward
director
$103k
89,250 shares
+60%
23Weak
NSPRbuy
InspireMD, Inc.
Paul Stuka
director
$4,905
2,710 shares
+1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gary S Roubin bought $127k of NSPR | InsiderTell